Study of Changes in Skeletal Muscle After Caloric Restriction
Diacylglycerols and Insulin Action in Skeletal Muscle Upon Caloric Restriction
1 other identifier
observational
24
1 country
1
Brief Summary
Research has shown that fat stored within muscles affects the muscle's sensitivity to insulin and ability to handle blood glucose. The purpose of this study is to examine the effects of weight loss surgery-induced caloric restriction on the accumulation and types of fats within skeletal muscle, as well as the effects of such caloric restriction on insulin sensitivity and inflammatory responses in skeletal muscle. The investigator proposes that caloric restriction will result in decreases in diacylglycerols enriched with saturated fat and increases in diacylglycerols enriched with monounsaturated fats.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2009
CompletedFirst Posted
Study publicly available on registry
October 12, 2009
CompletedStudy Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
ExpectedJuly 8, 2025
July 1, 2025
2.7 years
October 7, 2009
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
UPLC-ESI MS/MS profiling of lipd extracts from muscle biopsies to evaluate effects of gastric bypass induced-caloric restriction on diacylglycerol molecular species accumulation.
1 year
Secondary Outcomes (2)
To evaluate the effects of gastric bypass induced-caloric restriction on skeletal muscle insulin action via a hyperinsulinemic-euglycemic clamp and profiling markers of insulin signaling.
1 year
To evaluate the effects of gastric bypass induced-caloric restriction on lipid-mediated inflammatory responses by profiling cytokines and free fatty acids in blood and inflammation markers in skeletal muscle biopsies.
1 year
Study Arms (2)
Normal body weight
Female subjects, ages 21-65 yrs, with BMI of 21-27 kg/m2 with normal glucose tolerance.
Roux-en-Y gastric bypass
Female subjects ages 21-65 with insulin resistance and scheduled for Roux-en-Y gastric bypass at Vanderbilt University Medical Center will be studied before and 4-6 weeks after surgery.
Eligibility Criteria
Female subjects approved for Roux-en-Y gastric bypass surgery at Vanderbilt University Medical Center.
You may qualify if:
- For Normal Weight Subjects:
- Age 21-65 years
- BMI of 21 to 27 kg/m2
- Normal glucose tolerance as determined by OGTT on day of screening
- No family history of diabetes
- For Morbidly Obese Subjects:
- Age 21-65 years
- BMI of 30 to 65 kg/m2
- Scheduled for Roux-en-Y gastric bypass at Vanderbilt Medical Center
- Insulin resistant as determined by OGTT on day of screening
You may not qualify if:
- Clinically significant heart disease
- Clinically significant hepatic or renal disease
- Pregnancy
- Breastfeeding
- Any abnormality that would preclude safe completion of study
- Use of statins
- Use of thiazide or furosemide diuretics, beta blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless subject has been on stable dose of such medications for the past 3 months before entering the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Biospecimen
Whole blood, plasma, muscle tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles R Flynn, PhD
Vanderbilt University Medical Center
- STUDY CHAIR
Naji Abumrad, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 7, 2009
First Posted
October 12, 2009
Study Start
March 1, 2011
Primary Completion
November 1, 2013
Study Completion (Estimated)
November 1, 2026
Last Updated
July 8, 2025
Record last verified: 2025-07